This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • A Study of Rebif� in Subjects With Relapsing Multi...
Clinical trial

A Study of Rebif� in Subjects With Relapsing Multiple Sclerosis (RELIEF)

Read time: 1 mins
Last updated:13th Feb 2014

This is an open-label, multi-center, 12-week, randomized, controlled, parallel group, Phase 4 study to assess whether the morning administration of interferon beta 1a (Rebif®) leads to a lower severity of flu-like symptoms (FLS) as compared to the evening administration, in subjects with relapsing multiple sclerosis (RMS).

Category Value
Study start date 2014-02-13

View full details